CL2025003884A1
(es )
2026-03-06
Degradadores de smarca2 y usos de estos.
CL2025003930A1
(es )
2026-03-13
Derivados de 3-[3-amino-6-(2-hidroxifenil)piridazin-4-il]-3,8-diazabiciclo[3.2.1]octano como protacs degradadores de smarca2 para el tratamiento del cáncer.
BR102023014872A2
(https= )
2023-09-05
BR102023012440A2
(https= )
2023-08-22
BR102023010976A2
(https= )
2023-07-25
BR102023009641A2
(https= )
2023-08-22
BR102023008688A2
(https= )
2023-06-20
BR102023007252A2
(https= )
2023-06-06
BR102023005164A2
(https= )
2023-05-23
BR102023001877A2
(https= )
2023-06-20
BR102023000289A2
(https= )
2023-07-04
BR102022026909A2
(https= )
2023-06-20
BR202022001779U2
(https= )
2022-05-04
BR202022000931U2
(https= )
2023-07-04
CN307046197S
(https= )
2022-01-04
BY13167U
(https= )
2023-04-30
BY13152U
(https= )
2023-04-30
BY13165U
(https= )
2023-04-30
BY13162U
(https= )
2023-04-30
BY13161U
(https= )
2023-04-30
BY13160U
(https= )
2023-04-30
CN307047177S
(https= )
2022-01-04
BY13159U
(https= )
2023-04-30
BY13137U
(https= )
2023-04-30
BY13166U
(https= )
2023-04-30